<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-96049" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Autoimmune Pancreatitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basyal</surname>
            <given-names>Bikash</given-names>
          </name>
          <aff>Abington Jefferson Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>KC</surname>
            <given-names>Pawan</given-names>
          </name>
          <aff>Lexington Medical Center: Wake Forest Baptist Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bikash Basyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pawan KC declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-96049.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Autoimmune pancreatitis is a clinical condition characterized by inflammation of the pancreas from an autoimmune etiology. It is an uncommon cause of pancreatitis but can present with significant morbidity and mortality because of repeated episodes of acute pancreatitis. It can be associated with other autoimmune conditions, and timely diagnosis and management are important to achieve good patient outcomes. This activity reviews the evaluation and management of autoimmune pancreatitis and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of autoimmune pancreatitis as an autoimmune process and associations of the entity with other diseases.</p></list-item><list-item><p>Identify the clinical presentation of autoimmune pancreatitis.</p></list-item><list-item><p>Review the management of autoimmune pancreatitis including corticosteroids and the choice of immunomodulators in managing the condition.</p></list-item><list-item><p>Outline the importance of collaboration and coordination among the interprofessional team to improve recognition and treatment of patients with autoimmune pancreatitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96049&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96049">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-96049.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Autoimmune pancreatitis (AIP), also referred to as non-alcoholic destructive pancreatitis and sclerosing pancreatitis, is a chronic inflammatory condition characterized histologically by chronic inflammation of the pancreas and clinically by various symptoms related to biliary and pancreatic pathologies.<xref ref-type="bibr" rid="article-96049.r1">[1]</xref>&#x000a0;It is increasingly being recognized as an uncommon but important cause of recurrent acute pancreatitis or painless jaundice.<xref ref-type="bibr" rid="article-96049.r2">[2]</xref>&#x000a0;In addition to primarily being a pancreatic disorder, it is also being suggested as a systemic autoimmune disease&#x000a0;that can be present along with other autoimmune conditions or as a part of the spectrum of immunoglobin G subclass 4 (IgG4) related disorders.<xref ref-type="bibr" rid="article-96049.r3">[3]</xref><xref ref-type="bibr" rid="article-96049.r4">[4]</xref></p>
        <p>AIP has been classified into two clinical subtypes</p>
        <list list-type="bullet">
          <list-item>
            <p>Type 1: IgG4 related pancreatitis, associated with high serum IgG4 concentration and IgG4 bearing plasma cell infiltration of the pancreas with a background of lymphoplasmacytic sclerosing pancreatitis.&#x000a0;IgG4 related pancreatitis is associated with high serum IgG4 concentration and IgG4 bearing plasma cell infiltration of the pancreas with a background of lymphoplasmacytic sclerosing pancreatitis.</p>
          </list-item>
          <list-item>
            <p>Type 2: Idiopathic duct centric pancreatitis, granulocytic epithelial lesions in pancreatic duct without IgG4 positive cells or systemic involvement</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-96049.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of autoimmune pancreatitis is considered to be autoimmune,&#x000a0;as demonstrated by the presence of lymphocytic infiltration on histology.<xref ref-type="bibr" rid="article-96049.r3">[3]</xref>&#x000a0;As an IgG4 related disease, various immune-mediated mechanisms have been suggested that could initiate the inflammatory response.<xref ref-type="bibr" rid="article-96049.r5">[5]</xref>&#x000a0;Some&#x000a0;potential&#x000a0;initiating mechanisms include bacterial infection and molecular mimicry in the setting of genetic risk factors and autoimmunity. T-regulatory cells mediated immune reaction and the shift of peripheral blood T lymphocytes towards T helper 2 response could also contribute to the recruitment of cytokines and interleukins that subsequently induce inflammation and fibrosis.<xref ref-type="bibr" rid="article-96049.r5">[5]</xref>&#x000a0;The IgG4&#x000a0;antibodies are thought to behave as tissue-destructive immunoglobulins both locally and systemically, but there remains a gap in the understanding of the etiology of many IgG4-related diseases.<xref ref-type="bibr" rid="article-96049.r6">[6]</xref></p>
      </sec>
      <sec id="article-96049.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Autoimmune pancreatitis is an uncommon cause of chronic and recurrent pancreatitis and is likely an underdiagnosed condition. It is reported to account for up to 2% of all cases of chronic pancreatitis, with a prevalence of less than 1 per 100,000 population. Most of the initial reports in the literature are from Asian countries, including Japan, where the prevalence is speculated to be higher; however, this may partly have been because of increased recognition.<xref ref-type="bibr" rid="article-96049.r7">[7]</xref>&#x000a0;In recent years, it has increasingly been reported in Western countries, making it a worldwide entity.<xref ref-type="bibr" rid="article-96049.r8">[8]</xref></p>
        <p>Most of the epidemiological data about AIP has been based on estimates from small case series and study groups. It has been seen more in males with a ratio of 3:1, and the age of onset is reported to be greater than 45 years.<xref ref-type="bibr" rid="article-96049.r9">[9]</xref></p>
      </sec>
      <sec id="article-96049.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A histopathologic examination can help and is usually necessary to distinguish autoimmune pancreatitis from pancreatic cancer.<xref ref-type="bibr" rid="article-96049.r10">[10]</xref><xref ref-type="bibr" rid="article-96049.r11">[11]</xref>&#x000a0;The autoimmune nature of AIP is supported by the presence of lymphoproliferative inflammation demonstrated on histology. On biopsy, dense lymphoplasmacytic infiltrates can be seen, especially in and around pancreatic ducts with associated fibrosis.<xref ref-type="bibr" rid="article-96049.r12">[12]</xref>&#x000a0;Fibrosis may be similar to chronic obstructive pancreatitis, with the presence of both interlobular and intralobular fibrosis along with acinar atrophy.&#x000a0;</p>
        <p>A histopathologic picture of sclerosing pancreatitis or a presence of IgG4 positive cells along with periductal lymphoplasmacytic infiltration, acinar fibrosis, or obliterative phlebitis can establish a diagnosis of AIP type 1. AIP type 2 is characterized by the lack of IgG4 positive cells in pancreatic parenchyma and granulocytic epithelial lesions in the pancreatic duct.<xref ref-type="bibr" rid="article-96049.r10">[10]</xref></p>
      </sec>
      <sec id="article-96049.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinically, autoimmune pancreatitis can manifest with symptoms related to biliary or pancreatic involvement. Patients can present with recurrent episodes of abdominal pain, with or without attacks of pancreatitis. Obstructive jaundice is a common presentation that can be accompanied by non-specific symptoms such as nausea, vomiting, loss of appetite, or weight loss, depending on the degree of biliary or pancreatic strictures and involvement.<xref ref-type="bibr" rid="article-96049.r13">[13]</xref>&#x000a0;A physical examination can be non-revealing, except for mild jaundice, but it can help in ruling out an alternate diagnosis, causing abdominal pain.&#x000a0;</p>
        <p>Patients can also have other organ system involvement manifestations, such as salivary glands, thyroid, and renal involvement, associated with autoimmune pancreatitis. This is usually part of systemic IgG4-related disorders.</p>
      </sec>
      <sec id="article-96049.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis include imaging of the pancreas and pancreatic duct, serologic studies including IgG4 levels, histopathology, and other associated conditions.<xref ref-type="bibr" rid="article-96049.r14">[14]</xref>&#x000a0;Evaluating patients with suspected AIP involves laboratory tests, including a complete blood count and a comprehensive metabolic panel, with liver and kidney function tests. An obstructive pattern of transaminitis with elevated alkaline phosphatase and bilirubin levels may be noted.&#x000a0;</p>
        <p>Imaging of biliary and pancreatic systems can be done with a computed tomography (CT) scan or magnetic resonance imaging (MRI), which also helps to evaluate for alternate diagnoses. MRI scans, along with cholangiopancreatogram (MRCP), are generally considered superior to evaluate for size, textures, enhancement with contrast as well as the presence of strictures.<xref ref-type="bibr" rid="article-96049.r15">[15]</xref>&#x000a0;When expertise is available, endoscopic ultrasound of the pancreas is favored because of its utility in imaging, image-enhancing techniques, and the ability to acquire tissue through fine needle aspiration or biopsy.<xref ref-type="bibr" rid="article-96049.r16">[16]</xref><xref ref-type="bibr" rid="article-96049.r17">[17]</xref></p>
      </sec>
      <sec id="article-96049.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is limited data on the treatment of autoimmune pancreatitis, and most of it is based on observational studies. Most patients are seen to respond to corticosteroid therapy, which leads to improvement of symptoms as well as a reduction in complications of AIP.<xref ref-type="bibr" rid="article-96049.r18">[18]</xref>&#x000a0;In patients presenting with obstructive jaundice and sclerosing cholangitis, early initiation of corticosteroids is recommended.<xref ref-type="bibr" rid="article-96049.r18">[18]</xref>&#x000a0;It has been suggested that a lack of improvement with corticosteroids could hint towards the possibility of alternate diagnoses such as pancreatic malignancy.<xref ref-type="bibr" rid="article-96049.r19">[19]</xref></p>
        <p>Relapse of AIP or failure to wean steroids may occur in up to half of the patients, especially in IgG4-related AIP requiring long-term steroids or use of steroid-sparing agents. Azathioprine has been shown to be effective in patients to help in weaning steroid therapy.<xref ref-type="bibr" rid="article-96049.r20">[20]</xref>&#x000a0;Patients with biliary strictures are also at high risk for relapse after withdrawal of steroid therapy.<xref ref-type="bibr" rid="article-96049.r13">[13]</xref>&#x000a0;The role of other immunomodulators in treating frequent relapses of AIP, which is more common in type I AIP, is still being debated. Because of the lack of established guidelines, therapy needs to be tailored in individual patients.<xref ref-type="bibr" rid="article-96049.r21">[21]</xref></p>
      </sec>
      <sec id="article-96049.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>One of the important differentials that need to be ruled out before initiating treatment of autoimmune pancreatitis is pancreatic cancer. It may be difficult to differentiate the two based on clinical presentation or imaging findings alone.<xref ref-type="bibr" rid="article-96049.r22">[22]</xref>&#x000a0;Histopathological examination can be of yield and is preferred as a part of diagnostic criteria before initiating treatment of AIP.</p>
        <p>Other differential diagnoses that need to be considered are other causes of biliary tract obstruction, such as choledocholithiasis, cholangiocarcinoma, pancreatic cysts, scarring, or other pathologies that can contribute to the obstruction of pancreatic ducts.</p>
      </sec>
      <sec id="article-96049.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Autoimmune pancreatitis responds generally well to treatment with corticosteroids and has a favorable prognosis. A majority of cases exhibit remission with steroids, and the rate of complications is also reported to improve significantly with treatment. The cases of AIP that have a concurrent pancreatic tumor are challenging to treat and carry a worse prognosis that can be associated with the need for pancreatic resection.<xref ref-type="bibr" rid="article-96049.r22">[22]</xref></p>
      </sec>
      <sec id="article-96049.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Recurrent attacks of pancreatitis may present as pancreatic relapse in a few patients. There have been reports of the incidence of pancreatic cancer on the surveillance of patients with AIP; however, the association of AIP with malignancies is not established.<xref ref-type="bibr" rid="article-96049.r23">[23]</xref>&#x000a0;In cases that fail treatment or if there is suspicion of concurrent malignancy, surgical resection remains an option,&#x000a0;and surgery can be associated with significant morbidity and mortality.<xref ref-type="bibr" rid="article-96049.r24">[24]</xref></p>
        <p>The other complications of AIP are related to the worsening of biliary strictures and, if untreated, cause significant obstructive jaundice. There can also be complications related to long-term treatment with steroids, failure to wean steroids, or other complications secondary to immunomodulatory therapy.</p>
      </sec>
      <sec id="article-96049.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with autoimmune pancreatitis should be thoroughly educated regarding the treatment options for their condition. The importance of medication adherence and the consequences of inadequate treatment should be explained in detail. They should also be made aware of the potential side effects of long-term corticosteroid use, including&#x000a0;adrenal insufficiency, osteoporosis, weight gain, osteonecrosis, and hyperglycemia.</p>
      </sec>
      <sec id="article-96049.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Autoimmune pancreatitis can present with a diagnostic challenge because of nonspecific presentation with symptoms of abdominal pain and frequent episodes similar to acute pancreatitis. Patients can present to their primary care providers or in an emergency setting with these complaints. Diagnostic workup involves&#x000a0;an interprofessional approach including gastroenterologists for possible endoscopic intervention, radiologists for imaging as well as rheumatologists for evaluation of other associated autoimmune conditions. The role of nursing is also vital as a member of the interprofessional group with monitoring vital signs and educating patients and their family members.</p>
        <p>After a thorough evaluation and after ruling out differential diagnoses such as pancreatic malignancy, patients need continuous follow-up with their providers to assess their response to immunosuppressant therapy. Care coordination in both inpatient and outpatient settings remains critical to enhancing healthcare outcomes for the condition, reducing associated morbidity, and improving patient quality of life.</p>
      </sec>
      <sec id="article-96049.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96049&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96049">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/96049/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=96049">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-96049.s15">
        <title>References</title>
        <ref id="article-96049.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsubayashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kakushima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takizawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hotta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of autoimmune pancreatitis.</article-title>
            <source>World J Gastroenterol</source>
            <year>2014</year>
            <month>Nov</month>
            <day>28</day>
            <volume>20</volume>
            <issue>44</issue>
            <fpage>16559</fpage>
            <page-range>16559-69</page-range>
            <pub-id pub-id-type="pmid">25469024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagpal</surname>
                <given-names>SJS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune Pancreatitis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>113</volume>
            <issue>9</issue>
            <fpage>1301</fpage>
            <pub-id pub-id-type="pmid">29910463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamisawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Egawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune pancreatitis is a systemic autoimmune disease.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>98</volume>
            <issue>12</issue>
            <fpage>2811</fpage>
            <page-range>2811-2</page-range>
            <pub-id pub-id-type="pmid">14687846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Umemura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawa</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Immunogenetics of IgG4-Related AIP.</article-title>
            <source>Curr Top Microbiol Immunol</source>
            <year>2017</year>
            <volume>401</volume>
            <fpage>35</fpage>
            <page-range>35-44</page-range>
            <pub-id pub-id-type="pmid">27832379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Zen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>IgG4-related disease.</article-title>
            <source>N Engl J Med</source>
            <year>2012</year>
            <month>Feb</month>
            <day>09</day>
            <volume>366</volume>
            <issue>6</issue>
            <fpage>539</fpage>
            <page-range>539-51</page-range>
            <pub-id pub-id-type="pmid">22316447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kubo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>IgG4-related disease.</article-title>
            <source>Int J Rheum Dis</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>747</fpage>
            <page-range>747-62</page-range>
            <pub-id pub-id-type="pmid">26259069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimori</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tamakoshi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Otsuki</surname>
                <given-names>M</given-names>
              </name>
              <collab>Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan</collab>
            </person-group>
            <article-title>Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002.</article-title>
            <source>J Gastroenterol</source>
            <year>2007</year>
            <month>May</month>
            <volume>42 Suppl 18</volume>
            <fpage>6</fpage>
            <page-range>6-8</page-range>
            <pub-id pub-id-type="pmid">17520216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune pancreatitis: it may be a worldwide entity.</article-title>
            <source>Gastroenterology</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>1214</fpage>
            <pub-id pub-id-type="pmid">15057766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Phillip</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Alg&#x000fc;l</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, clinical presentation, diagnosis and treatment of autoimmune pancreatitis: A retrospective analysis of 53 patients.</article-title>
            <source>Pancreatology</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-7</page-range>
            <pub-id pub-id-type="pmid">26694138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smyrk</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Clain</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Topazian</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vege</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>1097</fpage>
            <page-range>1097-103</page-range>
            <pub-id pub-id-type="pmid">19410017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takase</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukumura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kashiwagi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pathology of autoimmune pancreatitis and tumor-forming pancreatitis.</article-title>
            <source>J Gastroenterol</source>
            <year>2007</year>
            <month>May</month>
            <volume>42 Suppl 18</volume>
            <fpage>22</fpage>
            <page-range>22-7</page-range>
            <pub-id pub-id-type="pmid">17520219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takase</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukumura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Histopathologic characteristics of autoimmune pancreatitis based on comparison with chronic pancreatitis.</article-title>
            <source>Pancreas</source>
            <year>2005</year>
            <month>May</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-8</page-range>
            <pub-id pub-id-type="pmid">15841047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghazale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Smyrk</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Topazian</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Clain</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Vege</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Farnell</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.</article-title>
            <source>Gastroenterology</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>706</fpage>
            <page-range>706-15</page-range>
            <pub-id pub-id-type="pmid">18222442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimosegawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Frulloni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kamisawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mino-Kenudson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kl&#x000f6;ppel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lerch</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Notohara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okazaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <collab>International Association of Pancreatology</collab>
            </person-group>
            <article-title>International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.</article-title>
            <source>Pancreas</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>352</fpage>
            <page-range>352-8</page-range>
            <pub-id pub-id-type="pmid">21412117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Byun</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.</article-title>
            <source>Eur Radiol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>5267</fpage>
            <page-range>5267-5274</page-range>
            <pub-id pub-id-type="pmid">29948075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujii-Lau</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>The Role of Endoscopic Ultrasound in the Diagnosis of Autoimmune Pancreatitis.</article-title>
            <source>Gastrointest Endosc Clin N Am</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>643</fpage>
            <page-range>643-655</page-range>
            <pub-id pub-id-type="pmid">28918803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cruise</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chahal</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic ultrasound guided 22 gauge core needle biopsy for the diagnosis of Autoimmune pancreatitis.</article-title>
            <source>Pancreatology</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>168</fpage>
            <page-range>168-169</page-range>
            <pub-id pub-id-type="pmid">29338920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Isayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yagioka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kogure</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasahira</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsujino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Omata</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.</article-title>
            <source>Gut</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>1719</fpage>
            <page-range>1719-24</page-range>
            <pub-id pub-id-type="pmid">17525092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moon</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.</article-title>
            <source>Gut</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>12</issue>
            <fpage>1704</fpage>
            <page-range>1704-12</page-range>
            <pub-id pub-id-type="pmid">18583399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandanayake</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>NI</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Dhar</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Deheragoda</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Winstanley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodriguez-Justo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hatfield</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>1089</fpage>
            <page-range>1089-96</page-range>
            <pub-id pub-id-type="pmid">19345283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okazaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Frulloni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lerch</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kamisawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>L&#x000e9;vy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Masamune</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shimosegawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>International consensus for the treatment of autoimmune pancreatitis.</article-title>
            <source>Pancreatology</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">28027896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xiang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.</article-title>
            <source>BMC Cancer</source>
            <year>2019</year>
            <month>Aug</month>
            <day>16</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>814</fpage>
            <pub-id pub-id-type="pmid">31419961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Uetsuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yashika</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gibo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fujishiro</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risks and characteristics of pancreatic cancer and pancreatic relapse in autoimmune pancreatitis patients.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>12</issue>
            <fpage>2281</fpage>
            <page-range>2281-2288</page-range>
            <pub-id pub-id-type="pmid">32583452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96049.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickerson</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Farooq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kleeff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raraty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghaneh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Whelan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Healey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Neoptolemos</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>VS</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging.</article-title>
            <source>World J Surg</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>1604</fpage>
            <page-range>1604-1611</page-range>
            <pub-id pub-id-type="pmid">30815742</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
